Algorics Releases New Version of Analytics Platform
Acuity now features enhanced site monitoring support, full tracking of insights into actions, and Japanese localization
Houston, TX - Algorics, a provider of cloud-based innovative clinical analytics solutions and software for the global life sciences industry, today announced the release of Acuity version 1.4.
Key features of the new release include:
Decision Factory – Site monitoring recommendation module
- The recent addendum to ICH E6 R2 recommends that the “Detection of deviations from the predefined quality tolerance limits should trigger an evaluation to determine if action is needed” Decision Factory provides statistical algorithm based ranking of the site risk based on how the site performs across study specific KRI thresholds. The sponsor also has control to change thresholds and KRIs during the study; all tracked in our audit trail.
Action Center – End-to-end workflow within Acuity to track insights into actions
- Teams can take advantage of the Action Center module to record findings captured while reviewing analytics in Acuity, assign to a team member with a priority level, and track the conversation history until the item is resolved. The traceability of insights to actions supplements the recent ICH E6 R2 need for reporting the outcomes of centralized monitoring.
Localization & Japanese support
- The Acuity analytics platform is now available with a Japanese language interface enabling Japanese users to monitor the data, and see visualizations in Kanji, as well as running all administrative functions in their chosen language. Global companies can bring together both Japanese and English language data in one environment.
Nithiya Ananthakrishnan, CEO of Algorics commented, “Our customers and partners feedback has directly driven the development of the latest version of Acuity. We understand that clinical data analytics is not just dashboard reporting but the need for end-to-end workflow that transforms insights to decisions and actions. This eliminates the risk of losing track of actions that should be taken post data analysis."
Rob Nichols, CCO of Algorics added “The Japanese localization enables us to support our customers and industry partners with a presence in Japan. We look forward to building an increased presence in the region and demonstrating the new and enhanced features.”
Meet us in March 2017 and find out more about the Acuity analytics platform:
March 21-22
Outsourcing in Clinical Trials South East 2017 - Cary, NC, USA
Clinical Data Integration & Management - Princeton, NJ, USA
March 23-24
OmniComm Innovation Forum Europe 2017 - Barcelona, Spain
March 26-31
SQA Annual Meeting - National Harbor, ND, USA
March 29-31
DIA Euromeeting - Glasgow, UK
About Algorics
Algorics brings together a team of highly experienced software and life sciences professionals, united behind a single goal: to provide innovative clinical analytics solutions and software to the global life sciences industry
with consistent and reliable quality. Algorics has a truly international presence, with offices in Doylestown, PA, Houston, TX (USA), London (UK) and Bangalore (India). Learn more by visiting www.algorics.com or
stay updated by following us on social media: Twitter, Facebook, LinkedIn
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
